Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 1, 2002, Pages 12-22

  Lee, Nancy ^a   Xia, Ping ^a   Quivey, Jeanne M ^a   Sultanem, Khalil ^a   Poon, Ian ^a   Akazawa, Clayton ^a   Akazawa, Pam ^a   Weinberg, Vivian ^a   Fu, Karen K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carcinoma; Intensity modulated; Nasopharynx; Radiotherapy

Indexed keywords

RADIOSURGERY;

CHEMOTHERAPY; DISEASES; DRUG DOSAGE; ONCOLOGY; SURGERY; TISSUE; TOXICITY;

RADIOTHERAPY;

CISPLATIN; FLUOROURACIL;

ADOLESCENT; ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLLIMATOR; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HISTOGRAM; HUMAN; IMAGE ANALYSIS; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION RESPONSE; SALIVARY GLAND; SURVIVAL RATE; SURVIVAL TIME; TECHNIQUE; TREATMENT OUTCOME; TUMOR VOLUME; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 0036569761     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02724-4     Document Type: Article

References (53)

1. Diet and nasopharyngeal carcinoma
2. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099
3. Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: Preliminary corroboration of the intergroup experience
4. Irradiation of nasopharyngeal carcinoma: Correlations with treatment factors and stage
5. Carcinoma of the nasopharynx: Eighteen years' experience with megavoltage radiation therapy
6. Megavoltage irradiation of epithelial tumors of the nasopharynx
7. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control
8. Nasopharyngeal carcinoma: Treatment results with primary radiation therapy
9. Improved survival in carcinoma of the nasopharynx
10. Carcinoma of the nasopharynx
11. Dose-response analysis for nasopharyngeal carcinoma
12. Patterns of failure in carcinoma of the nasopharynx: I Failure at the primary site
13. Intensity-modulated radiation therapy: A clinical review
14. Smart (simultaneous modulated accelerated radiation therapy) boost: A new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy
15. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: Techniques and early results
16. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer
17. Comparison of treatment plans involving intensity modulated radiotherapy for nasopharyngeal carcinoma
18. Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma
19. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer
20. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The University of California-San Francisco experience
21. A new applicator design for endocavitary brachytherapy of cancer in the nasopharynx
22. Three-dimensional motion analysis of an improved head immobilization system for simulation, CT, MRI, and PET imaging
23. Clinical experience with three dimensional treatment planning
24. Integrated 3-D conformal multivane intensity-modulation delivery system for radiotherapy
25. Peacock. A system for planning and rotational delivery of intensity modulated fields
26. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) [Editorial]
27. Nonparametric estimation from incomplete observations
28. Regression models and life-tables
29. Managing nasopharyngeal carcinoma with intracavitary brachytherapy: One institution's 45 year experience
30. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years' experience at Long Beach Memorial
31. The role of brachytherapy in early-stage nasopharyngeal carcinoma
32. Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: Impact on local control
33. New prognostic factors in nasopharyngeal carcinoma
34. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy: Proposal for standardizing terminology procedure based on the surgical experience
35. Imaging-based nodal classification for evaluation of neck metastatic adenopathy
36. A three-dimensional CT-based target definition for elective irradiation of the neck
37. Treatment portals for elective radiotherapy of the neck: An inventory in the Netherlands
38. An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classification
39. Cross-sectional nodal atlas: A tool for the definition of clinical target volumes in three-dimensional radiation therapy planning
40. Computer simulated patient motion and setup uncertainties in intensity modulated radiotherapy
41. Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumors
42. Three dimensional variability in patient positional using bite block immobilization in 3D-conformal radiation treatment for ENT tumors
43. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer
44. The early changes in salivary gland function during and after radiotherapy given for head and neck cancer
45. Some factors influencing salivary function when treating with radiotherapy
46. Detailed quality of life assessment in patients treated with primary radiotherapy for cancer of the base of tongue
47. Osteoradionecrosis of the mandible: A review
48. Late effects of radiation therapy in the head and neck region
49. Effects of radiotherapy on whole saliva flow